Daniel J. O'Connor

Insider Reports History

Location
C/O Seelos Therapeutics, Inc., 300 Park Avenue, 12 Th Floor, New York, NY
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. O'Connor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. President and CEO, Director Ordinary Shares 2.75M $29.4M $10.67 Apr 26, 2023 Direct
Ambrx Biopharma, Inc. President and CEO, Director Common Stock 0 $0 $9.82 Mar 7, 2024 Direct
Ambrx Biopharma, Inc. President and CEO, Director Restricted Stock Units 0 $0 $9.82 Mar 7, 2024 Direct
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 0 $0 $3.65 Feb 20, 2025 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Common Stock 1.38M Dec 12, 2022 Indirect
Ambrx Biopharma Inc. President and CEO, Director Stock Option (right to buy) 1.22M Jul 5, 2023 Direct
Larkspur Health Acquisition Corp. Director, 10%+ Owner Class B common stock 202K Jan 6, 2022 Indirect
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Warrant (right to buy) 177K Dec 12, 2022 Indirect
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 64.2K Feb 20, 2025 Direct
Larkspur Health Acquisition Corp. Director, 10%+ Owner Class A Common Stock 42K Jan 6, 2022 Indirect
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 1.75K Dec 12, 2022 Direct
ZyVersa Therapeutics, Inc. Director, 10%+ Owner Warrant (right to buy) 1.75K Dec 12, 2022 Direct
SEELOS THERAPEUTICS, INC. Director Stock Option (right to buy) 1.67K Jan 4, 2024 Direct
Ambrx Biopharma, Inc. President and CEO, Director Option to Purchase Common Stock 0 Mar 7, 2024 Direct

Insider Reports Filed by Daniel J. O'Connor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Feb 20, 2025 1 $0 4 Feb 24, 2025 Director
DMAC DiaMedica Therapeutics Inc. Feb 20, 2025 0 $0 3 Feb 24, 2025 Director
AMAM Ambrx Biopharma, Inc. Mar 7, 2024 5 $0 4 Mar 7, 2024 President and CEO, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 4, 2024 1 $0 4 Jan 8, 2024 Director
AMAM Ambrx Biopharma, Inc. Dec 11, 2023 1 $0 4 Dec 11, 2023 President and CEO, Director
AMAM Ambrx Biopharma, Inc. Oct 27, 2023 1 -$491K 4 Oct 31, 2023 President and CEO, Director
AMAM Ambrx Biopharma Inc. Jul 5, 2023 1 $0 4 Jul 7, 2023 President and CEO, Director
AMAM Ambrx Biopharma Inc. Apr 26, 2023 1 $0 4 Apr 28, 2023 President and CEO, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 5, 2023 1 $0 4 Jan 5, 2023 Director
AMAM Ambrx Biopharma Inc. Jan 1, 2023 0 $0 3 Jan 3, 2023 President and CEO, Director
ZVSA ZyVersa Therapeutics, Inc. Dec 12, 2022 4 $0 4 Dec 14, 2022 Director, 10%+ Owner
SEEL SEELOS THERAPEUTICS, INC. Jun 1, 2022 1 $9.79K 4 Jun 2, 2022 Director
ZVSA Larkspur Health Acquisition Corp. Jan 6, 2022 3 $0 4 Mar 10, 2022 Chief Executive Officer, Director
SEEL SEELOS THERAPEUTICS, INC. Jan 5, 2022 1 $0 4 Jan 6, 2022 Director
ZVSA Larkspur Health Acquisition Corp. Dec 20, 2021 0 $0 3 Dec 20, 2021 Chief Executive Officer, Director